Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations
Status:
Completed
Trial end date:
2017-07-31
Target enrollment:
Participant gender:
Summary
Ischemia reperfusion injury causes the release of free oxygen radicals. The selective
alpha2-receptor agonist, dexmedetomidine, has an inhibitory effect on inflammatory responses
during ischemic injury. The aim of this study is to evaluate the effect of dexmedetomidine on
inflammatory responses during ischemia-reperfusion injury in skeletal muscle.